Radium-223 (223Ra)
Radium-223 solution can be supplied in the several options — For specific requirements or technical specifications, please contact our production team.
We provide high-purity Ra-223 chloride, an alpha-emitting radionuclide clinically validated for bone-targeted radionuclide therapy (BNRT) in metastatic prostate cancer and skeletal metastases.
Availability Production status of isotope, categorized under one of the following:
Ra-223 Special order — advanced notice is necessary to obtain the product.
For more details please contact: export@mdcr.ru
Radium-223 (223Ra)
A proven alpha-emitting radionuclide for bone-targeted radionuclide therapy (BNRT), clinically validated in metastatic castration-resistant prostate cancer and other skeletal metastases. We supply GMP-grade Ra-223 chloride to streamline therapeutic workflows.
Availability Production status of isotope, categorized under one of the following:
Ra-223 Special order — advanced notice is necessary to obtain the product.
For more details please contact: export@mdcr.ru
Availability Production status of isotope, categorized under one of the following:
Ra-223 Special order — advanced notice is necessary to obtain the product.
For more details please contact: export@mdcr.ru
Connect with us